Back to Search Start Over

Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Authors :
D. R. Mani
Jennifer E. Van Eyk
Russell P. Grant
Gordon Whiteley
Juan A. Oses-Prieto
Amanda G. Paulovich
Robert Bethem
Arun P. Wiita
Raymond R. Townsend
Jerry S.H. Lee
John M. Koomen
Bradley L. Ackermann
Hendrik Neubert
Ruth Hüttenhain
Josip Blonder
Olga Vitek
Daniel W. Chan
Eric Kuhn
Susan T. Weintraub
Henry Rodriguez
Andrew N. Hoofnagle
Emily S. Boja
Susan E. Abbatiello
Alma L. Burlingame
Elizabeth Mansfield
Lukas Reiter
Eric W. Deutsch
Sang Won Lee
Bruno Domon
Ralph A. Bradshaw
Michael T. Boyne
Pothur R. Srinivas
James C. Ritchie
Nader Rifai
Hasmik Keshishian
Steven A. Carr
Robert L. Moritz
Tao Liu
Brendan MacLean
Daniel C. Liebler
Julianne Cook Botelho
Leigh Anderson
Ruedi Aebersold
Christoph H. Borchers
Christopher R. Kinsinger
Source :
Molecular & Cellular Proteomics, Molecular & cellular proteomics : MCP, vol 13, iss 3, Molecular & Cellular Proteomics : MCP
Publication Year :
2014
Publisher :
Elsevier BV, 2014.

Abstract

Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this “fit-for-purpose” approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.

Details

ISSN :
15359476
Volume :
13
Database :
OpenAIRE
Journal :
Molecular & Cellular Proteomics
Accession number :
edsair.doi.dedup.....6b0aec5f9092d06f07d3cb6fbcc1e643